Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SILO
#3953
Silo Pharma, Inc. Common Stock
0.3
7
+5.71%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+5.71%
Monthly Change
-2.63%
6 month change
-42.19%
Year Change
-72.59%
Previous Close
0.3
5
Open
0.3
7
Bid
Ask
Low
0.3
7
High
0.3
7
Volume
3
Markets
US Stock Market
Healthcare
SILO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
4.48 M
4.48 M
4.48 M
9.4 M
13.32 M
—
Valuation ratios
Enterprise value
72.01 K
85.37 K
2.11 M
1.59 M
5.27 M
9.06 M
Price to earnings ratio
-0.92
-0.75
-1.03
-0.62
-0.75
-3.14
Price to sales ratio
47.15
45.43
58.19
35.9
46.16
185.68
Price to cash flow ratio
-0.9
-0.85
-0.94
-0.5
-0.69
-2.99
Price to book ratio
0.14
0.65
0.19
0.12
0.18
1.14
Enterprise value to EBITDA ratio
—
-0.02
—
-0.31
-1
—
Profitability ratios
Return on assets %
-0.11
-0.23
-0.17
-0.18
-0.17
-0.76
Return on equity %
-0.14
-0.34
-0.26
-0.24
-0.22
-1.07
Return on invested capital %
-1 065.21
-1 935.59
-1 182.24
-1 388.27
-1 430.41
-5 936.51
Gross margin %
91.91
91.9
91.9
91.91
-14.77
260.94
Operating margin %
-5 603.63
-10.06 K
-6 069.68
-6 926.77
-6 388.16
-29.44 K
EBITDA margin %
-5 586.48
-10.04 K
-6 052.53
-6 913.05
-6 371.86
-29.38 K
Net margin %
-5 152.92
-9 600.69
-5 721.94
-6 681.24
-6 160.54
-28.16 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.91
4.29
4.73
6.07
8.7
23.8
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.31
-0.25
-0.37
-0.2
-0.1
-0.92
EBIT per share
-0.23
-0.49
-0.24
-0.2
-0.12
-1.06
EBITDA per share
-0.23
-0.49
-0.24
-0.2
-0.12
-1.06
Total debt per share
—
—
—
—
—
—
Cash per share
1.86
1.92
1.22
1
0.63
4.76
Net current asset value per share
1.92
1.93
1.25
1.01
0.66
4.86
Tangible book value per share
1.52
1.3
0.84
0.75
0.51
3.4
Working capital per share
1.68
1.48
0.99
0.85
0.58
3.9
Book value per share
1.58
1.37
0.89
0.78
0.54
3.58
News
Silo Pharma stock surges on $1M share buyback program
Silo Pharma authorizes $1 million stock buyback program
Japan grants patent for Silo Pharma’s PTSD treatment
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials
Silo Pharma CEO Weisblum buys $735 in company stock
Silo Pharma selects Allucent to support PTSD treatment IND submission
Silo Pharma selects Alphaledger T12 fund for blockchain asset investments
Silo Pharma shareholders approve equity plan amendment and reverse stock split proposal
Silo Pharma advances PTSD treatment, expands into crypto assets
Silo Pharma invests in ResearchCoin as part of digital assets strategy
Silo Pharma purchases ResearchCoin tokens for digital asset strategy
Silo Pharma closes $2.5 million registered direct offering